MiMedx Group secured a new three-year $50 million senior secured revolving credit facility with a group of lenders led by Bank of America Merrill Lynch.

“The facility may be used for general corporate purposes including new product introductions, clinical and scientific studies and strategic initiatives to expand the breadth of the organization”, said Parker H. “Pete” Petit, chairman and CEO.

MiMedx is an integrated developer, processor and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.